SUPPLEMENT

Q4 2024 — Non-GAAP reconciliations

Q4 2024PDF · 15 pages179 KB
The company reports its financial results in accordance with accounting principles generally accepted in the United States
(“GAAP” or referred to herein as “reported”). To supplement our consolidated financial statements reported on a GAAP
basis, we provide the following non-GAAP financial measures: “comparable net revenues,” “comparable currency neutral
net revenues,” “organic revenues,” “comparable operating margin,” “underlying operating margin,” “comparable operating
income,” “comparable currency neutral operating income,” “comparable EPS,” “comparable currency neutral EPS,”
“underlying effective tax rate,” “net share repurchases,” “cash flow from operations excluding the IRS tax litigation
deposit,” “projected cash flow from operations excluding the fairlife contingent consideration payment,” “free cash flow,”
“free cash flow excluding the IRS tax litigation deposit” and “projected free cash flow excluding the fairlife contingent
consideration payment” each of which is defined below. Management believes these non-GAAP financial measures
provide investors with additional meaningful financial information that should be considered when assessing our
underlying business performance and trends. Further, management believes these non-GAAP financial measures also
enhance investors’ ability to compare period-to-period financial results. Non-GAAP financial measures should be viewed
in addition to, and not as an alternative for, the company’s reported results prepared in accordance with GAAP. Our non-
GAAP financial measures do not represent a comprehensive basis of accounting. Therefore, our non-GAAP financial
measures may not be comparable to similarly titled measures reported by other companies. Reconciliations of each of
these non-GAAP financial measures to GAAP information are also included below. Management uses these non-GAAP
financial measures in making financial, operating, compensation and planning decisions and in evaluating the company’s
performance. Disclosing these non-GAAP financial measures allows investors and management to view our operating
results excluding the impact of items that are not reflective of the underlying operating performance.
DEFINITIONS
• “Currency neutral operating results” are determined by dividing or multiplying, as appropriate, our current period
actual U.S. dollar operating results, by the current period actual exchange rates (that include the impact of current
period currency hedging activities), to derive our current period local currency operating results. We then multiply or
divide, as appropriate, the derived current period local currency operating results by the foreign currency exchange
rates (that also include the impact of the comparable prior period currency hedging activities) used to translate the
company’s financial statements in the comparable prior year period to determine what the current period U.S. dollar
operating results would have been if the foreign currency exchange rates had not changed from the comparable
prior year period.
• “Structural changes” generally refer to acquisitions and divestitures of bottling operations, including the impact of
intercompany transactions between our operating segments. In January 2023, the company refranchised our
bottling operations in Vietnam. The impact of this refranchising has been included in acquisitions, divestitures and
structural changes in our analysis of net revenues on a consolidated basis as well as for the Bottling Investments
and Asia Pacific operating segments for the year ended December 31, 2024. In January, February and December
2024, the company refranchised our bottling operations in certain territories in India, and in February 2024, the
company refranchised our bottling operations in Bangladesh and the Philippines. The impact of each of these
refranchisings has been included in acquisitions, divestitures and structural changes in our analysis of net revenues
on a consolidated basis as well as for the Bottling Investments and Asia Pacific operating segments for the three
months and year ended December 31, 2024.
• “Comparable net revenues” is a non-GAAP financial measure that excludes or has otherwise been adjusted for
items impacting comparability (discussed further below). “Comparable currency neutral net revenues” is a
non-GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability
(discussed further below) as well as the impact of fluctuations in foreign currency exchange rates. Management
believes the comparable net revenues (non-GAAP) growth measure and the comparable currency neutral net
revenues (non-GAAP) growth measure provide investors with useful supplemental information to enhance their
understanding of the company’s revenue performance and trends by improving their ability to compare our period-
to-period results. “Organic revenues” is a non-GAAP financial measure that excludes or has otherwise been
adjusted for the impact of acquisitions, divestitures and structural changes, as applicable, and the impact of
fluctuations in foreign currency exchange rates. Management believes the organic revenue (non-GAAP) growth
measure provides users with useful supplemental information regarding the company’s ongoing revenue
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
16

-- 1 of 15 --

performance and trends by presenting revenue growth excluding the impact of foreign exchange as well as the
impact of acquisitions, divestitures and structural changes. The adjustments related to acquisitions, divestitures and
structural changes for the three months and year ended December 31, 2024 included the structural changes
discussed above. Additionally, in May 2023, the company acquired certain brands in Asia Pacific. The impact of
acquiring these brands has been included in acquisitions, divestitures and structural changes in our analysis of net
revenues on a consolidated basis as well as for the Asia Pacific operating segment for the year ended
December 31, 2024.
• “Comparable operating income” is a non-GAAP financial measure that excludes or has otherwise been adjusted for
items impacting comparability (discussed further below). “Comparable currency neutral operating income” is a non-
GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability (discussed
further below) and the impact of fluctuations in foreign currency exchange rates. “Comparable operating margin” is a
non-GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability
(discussed further below). “Underlying operating margin” is a non-GAAP financial measure that excludes or has
otherwise been adjusted for items impacting comparability (discussed further below), the impact of fluctuations in
foreign currency exchange rates, and the impact of acquisitions, divestitures and structural changes, as applicable.
Management uses these non-GAAP financial measures to evaluate the company’s performance and make resource
allocation decisions. Further, management believes the comparable operating income (non-GAAP) growth measure,
comparable currency neutral operating income (non-GAAP) growth measure, comparable operating margin (non-
GAAP) measure and underlying operating margin (non-GAAP) measure enhance its ability to communicate the
underlying operating results and provide investors with useful supplemental information to enhance their
understanding of the company’s underlying business performance and trends by improving their ability to compare
our period-to-period financial results.
• “Comparable EPS” and “comparable currency neutral EPS” are non-GAAP financial measures that exclude or have
otherwise been adjusted for items impacting comparability (discussed further below). Comparable currency neutral
EPS (non-GAAP) has also been adjusted for the impact of fluctuations in foreign currency exchange rates.
Management uses these non-GAAP financial measures to evaluate the company’s performance and make resource
allocation decisions. Further, management believes the comparable EPS (non-GAAP) and comparable currency
neutral EPS (non-GAAP) growth measures enhance its ability to communicate the underlying operating results and
provide investors with useful supplemental information to enhance their understanding of the company’s underlying
business performance and trends by improving their ability to compare our period-to-period financial results.
• “Underlying effective tax rate” is a non-GAAP financial measure that represents the estimated annual effective
income tax rate on income before income taxes, which excludes or has otherwise been adjusted for items impacting
comparability (discussed further below).
• “Net share repurchases” is a non-GAAP financial measure that reflects the net amount of purchases of stock for
treasury after considering proceeds from the issuances of stock, and as applicable, the net change in stock
issuance receivables (related to employee stock options exercised but not settled prior to the end of the period) and
the net change in treasury stock payables (for treasury shares repurchased but not settled prior to the end of the
period).
• “Cash flow from operations excluding the IRS tax litigation deposit” is a non-GAAP financial measure that
represents net cash provided by operating activities excluding the company’s IRS tax litigation deposit that was paid
in 2024. “Free cash flow” is a non-GAAP financial measure that represents net cash provided by operating activities
less purchases of property, plant and equipment. “Free cash flow excluding the IRS tax litigation deposit” is a non-
GAAP financial measure that represents net cash provided by operating activities less purchases of property, plant
and equipment and excludes the company’s IRS tax litigation deposit that was paid in 2024. “Projected cash flow
from operations excluding the fairlife contingent consideration payment” is a non-GAAP financial measure that
represents net cash provided by operating activities excluding the company’s latest estimate of the fairlife
contingent consideration payment that will be paid in 2025. “Projected free cash flow excluding the fairlife contingent
consideration payment” is a non-GAAP financial measure that represents net cash provided by operating activities
less purchases of property, plant and equipment and excludes the company’s latest estimate of the fairlife
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
17

-- 2 of 15 --

contingent consideration payment that will be paid in 2025. Management uses these non-GAAP financial measures
to evaluate the company’s performance and make resource allocation decisions.
ITEMS IMPACTING COMPARABILITY
The following information is provided to give qualitative and quantitative information related to items impacting
comparability. Items impacting comparability are not defined terms within GAAP. Therefore, our non-GAAP financial
information may not be comparable to similarly titled measures reported by other companies. We determine which items
to consider as “items impacting comparability” based on how management views our business; makes financial,
operating, compensation and planning decisions; and evaluates the company’s ongoing performance. Items such as
charges, gains and accounting changes which are viewed by management as impacting only the current period or the
comparable period, but not both, or as pertaining to different and unrelated underlying activities or events across
comparable periods, are generally considered “items impacting comparability.” Items impacting comparability include, but
are not limited to, asset impairments, transaction gains/losses including associated costs, and charges related to
restructuring initiatives, in each case when exceeding a U.S. dollar threshold. Also included are our proportionate share of
similar items incurred by our equity method investees, timing differences related to our economic (non-designated)
hedging activities, and timing differences related to unrealized mark-to-market adjustments of equity securities and trading
debt securities, regardless of size. In addition, we provide the impact that fluctuations in foreign currency exchange rates
had on our financial results (“currency neutral operating results” defined above).
Asset Impairments
During the three months and year ended December 31, 2024, the company recorded charges of $39 million and
$126 million, respectively, related to the impairment of a trademark in Latin America, which was primarily driven by revised
projections of future operating results and changes in macroeconomic conditions.
During the year ended December 31, 2024, the company recorded a charge of $760 million related to the impairment of
our BODYARMOR trademark, which was primarily driven by revised projections of future operating results and higher
discount rates resulting from changes in macroeconomic conditions since the acquisition date. Additionally, the company
recorded an other-than-temporary impairment charge of $34 million related to an equity method investee in Latin America.
During the three months and year ended December 31, 2023, the company recorded an other-than-temporary impairment
charge of $39 million related to an equity method investee in Latin America.
Equity Investees
During the three months and year ended December 31, 2024, the company recorded net charges of $47 million and
$92 million, respectively. During the three months and year ended December 31, 2023, the company recorded net
charges of $27 million and $159 million, respectively. These amounts represent the company’s proportionate share of
significant operating and nonoperating items recorded by certain of our equity method investees.
Transaction Gains/Losses
During the three months and year ended December 31, 2024, the company recorded charges of $88 million and
$3,109 million, respectively, related to the remeasurement of our contingent consideration liability to fair value in
conjunction with our acquisition of fairlife.
During the three months and year ended December 31, 2024, the company recorded net gains of $13 million and
$303 million, respectively, related to the refranchising of our bottling operations in certain territories in India, including the
impact of post-closing adjustments. Additionally, during the year ended December 31, 2024, the company incurred
$7 million of transaction costs related to the refranchising of our bottling operations in certain territories in India.
During the year ended December 31, 2024, the company recorded a net gain of $595 million related to the refranchising
of our bottling operations in the Philippines, including the impact of post-closing adjustments. Additionally, the company
recorded a net gain of $506 million related to the sale of our ownership interest in an equity method investee in Thailand,
including the impact of post-closing adjustments. The company also recorded a net gain of $338 million and transaction
costs of $2 million related to the sale of a portion of our interest in Coca-Cola Consolidated, Inc. (“Coke Consolidated”), an
equity method investee, to Coke Consolidated.
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
18

-- 3 of 15 --

During the year ended December 31, 2024, the company recorded a gain of $6 million related to the sale of our ownership
interest in one of our equity method investees in Latin America and recorded a loss of $7 million related to post-closing
adjustments for the refranchising of our bottling operations in Vietnam in 2023.
During the three months and year ended December 31, 2023, the company recorded charges of $82 million and
$1,702 million, respectively, related to the remeasurement of our contingent consideration liability to fair value in
conjunction with our acquisition of fairlife. Additionally, the company recorded a gain of $82 million related to the sale of
our ownership interest in our equity method investee in Pakistan.
During the year ended December 31, 2023, the company recognized a gain of $342 million related to the sale of a portion
of our ownership interest in an unconsolidated bottling operation. Additionally, the company recorded gains of $439 million
and $3 million related to the refranchising of our bottling operations in Vietnam and Cambodia, respectively.
Restructuring
During the three months and year ended December 31, 2024, the company recorded charges of $31 million and
$133 million, respectively. During the three months and year ended December 31, 2023, the company recorded charges
of $55 million and $164 million, respectively. The costs incurred were primarily related to certain initiatives designed to
further simplify and standardize our organization as part of our productivity and reinvestment program.
During the three months and year ended December 31, 2023, the company recorded charges of $1 million and
$27 million, respectively, primarily related to severance costs associated with the restructuring of our North America
operating unit.
Other Items
Economic (Non-Designated) Hedges
The company uses derivatives as economic hedges primarily to mitigate the foreign exchange risk for certain currencies,
certain interest rate risk, and the price risk associated with the purchase of materials used in our manufacturing processes
as well as the purchase of vehicle fuel. Although these derivatives were not designated and/or did not qualify for hedge
accounting, they are effective economic hedges. The changes in fair values of these economic hedges are immediately
recognized in earnings.
The company excludes the net impact of mark-to-market adjustments for outstanding hedges and realized gains/losses
for settled hedges from our non-GAAP financial information until the period in which the underlying exposure being
hedged impacts our consolidated statement of income. Management believes this adjustment provides meaningful
information related to the impact of our economic hedging activities. During the three months and year ended
December 31, 2024, the net impact of the company’s adjustment related to our economic hedging activities resulted in
decreases of $162 million and $138 million, respectively, to our non-GAAP income before income taxes.
During the three months and year ended December 31, 2023, the net impact of the company’s adjustment related to our
economic hedging activities resulted in increases of $107 million and $42 million, respectively, to our non-GAAP income
before income taxes.
Unrealized Gains and Losses on Equity and Trading Debt Securities
The company excludes the net impact of unrealized gains and losses resulting from mark-to-market adjustments on our
equity and trading debt securities from our non-GAAP financial information until the period in which the underlying
securities are sold and the associated gains or losses are realized, unless individually significant. Management believes
this adjustment provides meaningful information related to the impact of our investments in equity and trading debt
securities. During the three months and year ended December 31, 2024, the net impact of the company’s adjustment
related to unrealized gains and losses on our equity and trading debt securities resulted in an increase of $58 million and
a decrease of $206 million, respectively, to our non-GAAP income before income taxes.
During the three months and year ended December 31, 2023, the net impact of the company’s adjustment related to
unrealized gains and losses on our equity and trading debt securities resulted in a decrease of $163 million and an
increase of $15 million, respectively, to our non-GAAP income before income taxes.
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
19

-- 4 of 15 --

Other
During the three months and year ended December 31, 2024, the company recorded net charges of $2 million and
$19 million, respectively, related to restructuring our manufacturing operations in the United States. Additionally, the
company recorded charges of $4 million and $15 million, respectively, for the amortization of noncompete agreements
related to the BODYARMOR acquisition in 2021.
During the three months ended December 31, 2024, the company recorded a net charge of $1 million due to tax litigation
expense and during the year ended December 31, 2024, the company recorded a net benefit of $2 million related to a
revision of management’s estimates for tax litigation expense.
During the three months and year ended December 31, 2024, the company recorded a charge of $13 million related to an
indemnification agreement entered into as a part of the refranchising of certain bottling operations.
During the three months and year ended December 31, 2023, the company recorded a net charge of $61 million due to
pension and other postretirement benefit plan settlement charges. The company also recorded net charges of $35 million
and $50 million, respectively, related to restructuring our manufacturing operations in the United States. Additionally, the
company recorded charges of $4 million and $15 million, respectively, for the amortization of noncompete agreements
related to the BODYARMOR acquisition. The company also recorded charges of $1 million and $8 million, respectively,
related to tax litigation expense.
During the year ended December 31, 2023, the company recorded charges totaling $35 million related to the
discontinuation of certain manufacturing operations in Asia Pacific.
Certain Tax Matters
During the three months and year ended December 31, 2024, the company recorded $1 million and $62 million,
respectively, of excess tax benefits associated with the company’s stock-based compensation arrangements and net
income tax expense of $17 million and $50 million, respectively, primarily associated with return to provision adjustments.
The company also recorded net income tax expense of $39 million and a net income tax benefit of $2 million, respectively,
for changes to our uncertain tax positions, including interest and penalties, as well as for various discrete tax items.
Additionally, the company recorded net income tax expense of $19 million and $103 million, respectively, related to the
resolution of certain foreign tax matters and recorded expense of $2 million and $24 million, respectively, for other costs
directly related to those matters.
During the three months and year ended December 31, 2024, the company also recorded net income tax expense of
$15 million related to U.S. regulations issued during the year.
During the three months and year ended December 31, 2023, the company recorded $7 million and $40 million,
respectively, of excess tax benefits associated with the company’s stock-based compensation arrangements and net
income tax benefits of $10 million and $87 million, respectively, primarily associated with return to provision adjustments.
During the year ended December 31, 2023, the company recorded a net income tax benefit of $90 million related to a
change in tax law in a certain foreign jurisdiction and a net income tax benefit of $111 million for changes to our uncertain
tax positions, including interest and penalties, as well as for various discrete tax items.
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
20

-- 5 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions except per share data)
Three Months Ended December 31, 2024
Net
operating
revenues
Cost of
goods
sold Gross
profit Gross
margin
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income Operating
margin
Reported (GAAP) $ 11,544 $ 4,613 $ 6,931 60.0% $ 4,046 $ 176 $ 2,709 23.5%
Items Impacting Comparability:
Asset Impairments — — — — (39) 39
Equity Investees — — — — — —
Transaction Gains/Losses — — — — (88) 88
Restructuring — — — — (31) 31
Other Items (140) 13 (153) — (18) (135)
Certain Tax Matters — — — (2) — 2
Comparable (Non-GAAP) $ 11,404 $ 4,626 $ 6,778 59.4% $ 4,044 $ — $ 2,734 24.0%
Three Months Ended December 31, 2023
Net
operating
revenues
Cost of
goods
sold Gross
profit Gross
margin
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income Operating
margin
Reported (GAAP) $ 10,849 $ 4,634 $ 6,215 57.3% $ 3,799 $ 143 $ 2,273 21.0%
Items Impacting Comparability:
Asset Impairments — — — — — —
Equity Investees — — — — — —
Transaction Gains/Losses — — — — (82) 82
Restructuring — — — — (56) 56
Other Items 99 (17) 116 — (5) 121
Certain Tax Matters — — — — — —
Comparable (Non-GAAP) $ 10,948 $ 4,617 $ 6,331 57.8% $ 3,799 $ — $ 2,532 23.1%
Net
operating
revenues
Cost of
goods
sold Gross
profit
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income
% Change — Reported (GAAP) 6 0 12 7 24 19
% Currency Impact (3) (2) (3) (2) — (5)
% Change — Currency Neutral (Non-GAAP) 9 2 15 9 — 24
% Change — Comparable (Non-GAAP) 4 0 7 6 — 8
% Comparable Currency Impact (Non-GAAP) (5) (2) (7) (2) — (14)
% Change — Comparable Currency Neutral (Non-GAAP) 9 2 14 9 — 22
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
21

-- 6 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions except per share data)
Three Months Ended December 31, 2024
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1 Effective
tax rate Net
income3
Diluted
net
income
per share
Reported (GAAP) $ 431 $ 338 $ (14) $ 2,806 $ 593 21.1% $ 2,195 $ 0.51
Items Impacting Comparability:
Asset Impairments — — — 39 10 29 0.01
Equity Investees — 47 — 47 — 47 0.01
Transaction Gains/Losses — — (13) 75 19 56 0.01
Restructuring — — — 31 7 24 0.01
Other Items 7 — 58 (84) (23) (61) (0.01)
Certain Tax Matters — — — 2 (89) 91 0.02
Comparable (Non-GAAP) $ 438 $ 385 $ 31 $ 2,916 $ 517 17.7% 2 $ 2,381 $ 0.55
Three Months Ended December 31, 2023
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1 Effective
tax rate Net
income3
Diluted
net
income
per share
Reported (GAAP) $ 413 $ 361 $ (6) $ 2,482 $ 496 20.0% $ 1,973 $ 0.46
Items Impacting Comparability:
Asset Impairments — — 39 39 — 39 0.01
Equity Investees — 27 — 27 1 26 0.01
Transaction Gains/Losses — — (82) — (39) 39 0.01
Restructuring — — — 56 15 41 0.01
Other Items 6 — (70) 45 16 29 0.01
Certain Tax Matters — — — — 17 (17) —
Comparable (Non-GAAP) $ 419 $ 388 $ (119) $ 2,649 $ 506 19.1% $ 2,130 $ 0.49
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1 Net
income3
Diluted
net
income
per share
% Change — Reported (GAAP) 5 (6) (120) 13 20 11 12
% Change — Comparable (Non-GAAP) 4 (1) — 10 2 12 12
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
1 The income tax adjustments are the calculated income tax benefits (charges) at the applicable tax rate for each of the items impacting comparability
with the exception of certain tax matters discussed above.
2 This does not include the impact of the ongoing tax litigation with the U.S. Internal Revenue Service, if the company were not to prevail.
3 This represents net income attributable to shareowners of The Coca-Cola Company.
22

-- 7 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions except per share data)
Year Ended December 31, 2024
Net
operating
revenues
Cost of
goods
sold Gross
profit Gross
margin
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income Operating
margin
Reported (GAAP) $ 47,061 $ 18,324 $ 28,737 61.1% $ 14,582 $ 4,163 $ 9,992 21.2%
Items Impacting Comparability:
Asset Impairments — — — — (886) 886
Equity Investees — — — — — —
Transaction Gains/Losses — — — — (3,118) 3,118
Restructuring — — — — (133) 133
Other Items (164) (70) (94) — (26) (68)
Certain Tax Matters — — — (24) — 24
Comparable (Non-GAAP) $ 46,897 $ 18,254 $ 28,643 61.1% $ 14,558 $ — $ 14,085 30.0%
Year Ended December 31, 2023
Net
operating
revenues
Cost of
goods
sold Gross
profit Gross
margin
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income Operating
margin
Reported (GAAP) $ 45,754 $ 18,520 $ 27,234 59.5% $ 13,972 $ 1,951 $ 11,311 24.7%
Items Impacting Comparability:
Asset Impairments — — — — — —
Equity Investees — — — — — —
Transaction Gains/Losses — — — 11 (1,702) 1,691
Restructuring — — — — (191) 191
Other Items 30 (55) 85 — (58) 143
Certain Tax Matters — — — — — —
Comparable (Non-GAAP) $ 45,784 $ 18,465 $ 27,319 59.7% $ 13,983 $ — $ 13,336 29.1%
Net
operating
revenues
Cost of
goods
sold Gross
profit
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income
% Change — Reported (GAAP) 3 (1) 6 4 113 (12)
% Currency Impact (5) (3) (6) (4) — (11)
% Change — Currency Neutral (Non-GAAP) 8 2 12 8 — (1)
% Change — Comparable (Non-GAAP) 2 (1) 5 4 — 6
% Comparable Currency Impact (Non-GAAP) (5) (3) (7) (4) — (11)
% Change — Comparable Currency Neutral (Non-GAAP) 8 2 12 8 — 16
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
23

-- 8 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions except per share data)
Year Ended December 31, 2024
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1 Effective
tax rate Net
income3
Diluted
net
income
per share
Reported (GAAP) $ 1,656 $ 1,770 $ 1,992 $ 13,086 $ 2,437 18.6% $ 10,631 $ 2.46
Items Impacting Comparability:
Asset Impairments — — 34 920 222 698 0.16
Equity Investees — 92 — 92 2 90 0.02
Transaction Gains/Losses — — (1,741) 1,377 332 1,045 0.24
Restructuring — — — 133 33 100 0.02
Other Items 25 — (206) (299) (70) (229) (0.05)
Certain Tax Matters — — — 24 (104) 128 0.03
Comparable (Non-GAAP) $ 1,681 $ 1,862 $ 79 $ 15,333 $ 2,852 18.6% 2 $ 12,463 $ 2.88
Year Ended December 31, 2023
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1 Effective
tax rate Net
income3
Diluted
net
income
per share
Reported (GAAP) $ 1,527 $ 1,691 $ 570 $ 12,952 $ 2,249 17.4% $ 10,714 $ 2.47
Items Impacting Comparability:
Asset Impairments — — 39 39 — 39 0.01
Equity Investees — 159 — 159 14 145 0.03
Transaction Gains/Losses — — (855) 836 27 809 0.19
Restructuring — — — 191 48 143 0.03
Other Items 25 — 108 226 71 138 0.03
Certain Tax Matters — — — — 328 (328) (0.08)
Comparable (Non-GAAP) $ 1,552 $ 1,850 $ (138) $ 14,403 $ 2,737 19.0% $ 11,660 $ 2.69
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1 Net
income3
Diluted
net
income
per share
% Change — Reported (GAAP) 8 5 249 1 8 (1) 0
% Change — Comparable (Non-GAAP) 8 1 — 6 4 7 7
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
1 The income tax adjustments are the calculated income tax benefits (charges) at the applicable tax rate for each of the items impacting comparability
with the exception of certain tax matters discussed above.
2 This does not include the impact of the ongoing tax litigation with the U.S. Internal Revenue Service, if the company were not to prevail.
3 This represents net income attributable to shareowners of The Coca-Cola Company.
24

-- 9 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
Diluted Net Income Per Share:
Three Months Ended
December 31, 2024
% Change — Reported (GAAP) 12
% Currency Impact (1)
% Change — Currency Neutral (Non-GAAP) 13
% Impact of Items Impacting Comparability (Non-GAAP) (1)
% Change — Comparable (Non-GAAP) 12
% Comparable Currency Impact (Non-GAAP) (11)
% Change — Comparable Currency Neutral (Non-GAAP) 23
Year Ended
December 31, 2024
% Change — Reported (GAAP) 0
% Currency Impact (9)
% Change — Currency Neutral (Non-GAAP) 8
% Impact of Items Impacting Comparability (Non-GAAP) (8)
% Change — Comparable (Non-GAAP) 7
% Comparable Currency Impact (Non-GAAP) (9)
% Change — Comparable Currency Neutral (Non-GAAP) 17
Note: Certain columns may not add due to rounding.
25

-- 10 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions)
Net Operating Revenues by Operating Segment and Corporate:
Three Months Ended December 31, 2024
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Eliminations Consolidated
Reported (GAAP) $ 1,791 $ 1,643 $ 4,679 $ 1,216 $ 850 $ 1,551 $ 22 $ (208) $ 11,544
Items Impacting Comparability:
Other Items (30) (26) (14) (70) — — — — (140)
Comparable (Non-GAAP) $ 1,761 $ 1,617 $ 4,665 $ 1,146 $ 850 $ 1,551 $ 22 $ (208) $ 11,404
Three Months Ended December 31, 2023
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Eliminations Consolidated
Reported (GAAP) $ 1,690 $ 1,492 $ 4,040 $ 1,115 $ 813 $ 2,013 $ 31 $ (345) $ 10,849
Items Impacting Comparability:
Other Items 34 19 3 43 — — — — 99
Comparable (Non-GAAP) $ 1,724 $ 1,511 $ 4,043 $ 1,158 $ 813 $ 2,013 $ 31 $ (345) $ 10,948
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Eliminations Consolidated
% Change — Reported (GAAP) 6 10 16 9 5 (23) (31) 40 6
% Currency Impact (11) (15) 0 8 2 0 (1) — (3)
% Change — Currency Neutral
(Non-GAAP) 17 25 15 1 3 (23) (30) — 9
% Acquisitions, Divestitures and
Structural Changes 0 0 0 0 0 (30) 0 — (5)
% Change — Organic Revenues
(Non-GAAP) 17 25 15 1 3 7 (30) — 14
% Change — Comparable (Non-GAAP) 2 7 15 (1) 5 (23) (31) — 4
% Comparable Currency Impact
(Non-GAAP) (15) (18) 0 (2) 2 0 (1) — (5)
% Change — Comparable Currency
Neutral (Non-GAAP) 17 25 15 1 3 (23) (30) — 9
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
26

-- 11 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions)
Net Operating Revenues by Operating Segment and Corporate:
Year Ended December 31, 2024
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Eliminations Consolidated
Reported (GAAP) $ 8,122 $ 6,459 $ 18,649 $ 5,546 $ 3,129 $ 6,223 $ 97 $ (1,164) $ 47,061
Items Impacting Comparability:
Other Items (46) (46) (14) (58) — — — — (164)
Comparable (Non-GAAP) $ 8,076 $ 6,413 $ 18,635 $ 5,488 $ 3,129 $ 6,223 $ 97 $ (1,164) $ 46,897
Year Ended December 31, 2023
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Eliminations Consolidated
Reported (GAAP) $ 8,078 $ 5,830 $ 16,774 $ 5,455 $ 3,064 $ 7,860 $ 126 $ (1,433) $ 45,754
Items Impacting Comparability:
Other Items 1 4 — 25 — — — — 30
Comparable (Non-GAAP) $ 8,079 $ 5,834 $ 16,774 $ 5,480 $ 3,064 $ 7,860 $ 126 $ (1,433) $ 45,784
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Eliminations Consolidated
% Change — Reported (GAAP) 1 11 11 2 2 (21) (23) 19 3
% Currency Impact (16) (14) 0 (3) 2 (2) 0 — (5)
% Change — Currency Neutral
(Non-GAAP) 16 25 11 4 1 (19) (23) — 8
% Acquisitions, Divestitures and
Structural Changes 0 0 0 0 0 (28) 0 — (4)
% Change — Organic Revenues
(Non-GAAP) 16 25 11 4 1 9 (23) — 12
% Change — Comparable (Non-GAAP) 0 10 11 0 2 (21) (23) — 2
% Comparable Currency Impact
(Non-GAAP) (16) (15) 0 (4) 2 (2) 0 — (5)
% Change — Comparable Currency
Neutral (Non-GAAP) 16 25 11 4 1 (19) (23) — 8
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
27

-- 12 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions)
Operating Income (Loss) by Operating Segment and Corporate:
Three Months Ended December 31, 2024
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Consolidated
Reported (GAAP) $ 816 $ 985 $ 1,174 $ 388 $ 135 $ 199 $ (988) $ 2,709
Items Impacting Comparability:
Asset Impairments — 39 — — — — — 39
Transaction Gains/Losses — — — — — — 88 88
Restructuring — — — — — — 31 31
Other Items (30) (26) (27) (70) (4) 3 19 (135)
Certain Tax Matters 2 — — — — — — 2
Comparable (Non-GAAP) $ 788 $ 998 $ 1,147 $ 318 $ 131 $ 202 $ (850) $ 2,734
Three Months Ended December 31, 2023
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Consolidated
Reported (GAAP) $ 798 $ 797 $ 910 $ 313 $ 119 $ 185 $ (849) $ 2,273
Items Impacting Comparability:
Asset Impairments — — — — — — — —
Transaction Gains/Losses — — — — — — 82 82
Restructuring — — 1 — — — 55 56
Other Items 34 19 3 43 — 16 6 121
Certain Tax Matters — — — — — — — —
Comparable (Non-GAAP) $ 832 $ 816 $ 914 $ 356 $ 119 $ 201 $ (706) $ 2,532
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Consolidated
% Change — Reported (GAAP) 2 24 29 24 14 8 (16) 19
% Currency Impact (13) (18) 2 31 1 5 2 (5)
% Change — Currency Neutral (Non-GAAP) 15 42 27 (7) 13 3 (18) 24
% Impact of Items Impacting Comparability
(Non-GAAP) 7 1 3 35 4 7 4 11
% Change — Comparable (Non-GAAP) (5) 22 26 (11) 10 1 (20) 8
% Comparable Currency Impact (Non-GAAP) (20) (24) 0 (5) 1 4 2 (14)
% Change — Comparable Currency Neutral
(Non-GAAP) 14 46 26 (6) 9 (3) (23) 22
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
28

-- 13 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions)
Operating Income (Loss) by Operating Segment and Corporate:
Year Ended December 31, 2024
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Consolidated
Reported (GAAP) $ 4,125 $ 3,780 $ 4,336 $ 2,148 $ 359 $ 496 $ (5,252) $ 9,992
Items Impacting Comparability:
Asset Impairments — 126 760 — — — — 886
Transaction Gains/Losses — — — — — — 3,118 3,118
Restructuring — — — — — — 133 133
Other Items (46) (46) 56 (58) (2) 1 27 (68)
Certain Tax Matters 3 — — — — — 21 24
Comparable (Non-GAAP) $ 4,082 $ 3,860 $ 5,152 $ 2,090 $ 357 $ 497 $ (1,953) $ 14,085
Year Ended December 31, 2023
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Consolidated
Reported (GAAP) $ 4,202 $ 3,432 $ 4,435 $ 2,040 $ 329 $ 578 $ (3,705) $ 11,311
Items Impacting Comparability:
Asset Impairments — — — — — — — —
Transaction Gains/Losses — — — — — — 1,691 1,691
Restructuring — — 26 — — — 165 191
Other Items 1 4 48 60 — 8 22 143
Certain Tax Matters — — — — — — — —
Comparable (Non-GAAP) $ 4,203 $ 3,436 $ 4,509 $ 2,100 $ 329 $ 586 $ (1,827) $ 13,336
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Consolidated
% Change — Reported (GAAP) (2) 10 (2) 5 9 (14) (42) (12)
% Currency Impact (15) (17) 0 (2) 1 (1) 1 (11)
% Change — Currency Neutral (Non-GAAP) 14 27 (3) 7 8 (14) (43) (1)
% Impact of Items Impacting Comparability
(Non-GAAP) 1 (2) (16) 6 1 1 (35) (17)
% Change — Comparable (Non-GAAP) (3) 12 14 0 9 (15) (7) 6
% Comparable Currency Impact (Non-GAAP) (16) (18) 0 (6) 1 (1) 2 (11)
% Change — Comparable Currency Neutral
(Non-GAAP) 14 31 14 5 8 (15) (9) 16
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
29

-- 14 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
Operating Margin:
Three Months Ended
December 31, 2024 Three Months Ended
December 31, 2023 Basis Point
Growth (Decline)
Reported Operating Margin (GAAP) 23.47 % 20.95 % 252
Items Impacting Comparability (Non-GAAP) (0.49) % (2.17) %
Comparable Operating Margin (Non-GAAP) 23.96 % 23.12 % 84
Comparable Currency Impact (Non-GAAP) (1.82) % 0.00 %
Comparable Currency Neutral Operating Margin (Non-GAAP) 25.78 % 23.12 % 266
Impact of Acquisitions, Divestitures and Structural Changes on
Comparable Currency Neutral Operating Margin (Non-GAAP) 0.01 % (0.07) %
Underlying Operating Margin (Non-GAAP) 25.77 % 23.19 % 258
Year Ended
December 31, 2024 Year Ended
December 31, 2023 Basis Point
Growth (Decline)
Reported Operating Margin (GAAP) 21.23 % 24.72 % (349)
Items Impacting Comparability (Non-GAAP) (8.80) % (4.41) %
Comparable Operating Margin (Non-GAAP) 30.03 % 29.13 % 90
Comparable Currency Impact (Non-GAAP) (1.36) % 0.00 %
Comparable Currency Neutral Operating Margin (Non-GAAP) 31.39 % 29.13 % 226
Impact of Acquisitions, Divestitures and Structural Changes on
Comparable Currency Neutral Operating Margin (Non-GAAP) 0.11 % (0.57) %
Underlying Operating Margin (Non-GAAP) 31.28 % 29.70 % 158
Free Cash Flow (In millions):
Year Ended
December 31, 2024 Year Ended
December 31, 2023 $ Change % Change
Net Cash Provided by Operating Activities (GAAP) $ 6,805 $ 11,599 $ (4,794) (41)
Purchases of Property, Plant and Equipment (GAAP) (2,064) (1,852) (212) 11
Free Cash Flow (Non-GAAP) 4,741 9,747 (5,006) (51)
Plus: IRS Tax Litigation Deposit 6,041 — 6,041 —
Free Cash Flow Excluding the IRS Tax Litigation Deposit
(Non-GAAP) $ 10,782 $ 9,747 $ 1,035 11
Net Share Repurchases (In millions):
Year Ended
December 31, 2024
Issuances of Stock (GAAP) $ 747
Purchases of Stock for Treasury (GAAP) (1,795)
Net Change in Stock Issuance Receivables1 (GAAP) (7)
Net Share Repurchases (Non-GAAP) $ (1,055)
1 Represents the net change in receivables related to employee stock options exercised but not settled prior to the end of the period.
Projected 2025 Free Cash Flow Excluding the fairlife Contingent Consideration Payment (In billions):
Year Ending
December 31, 2025
Projected GAAP Net Cash Provided by Operating Activities $ 5.6
Plus: fairlife Contingent Consideration Payment 6.1
Projected Cash Flow from Operations Excluding the fairlife Contingent Consideration Payment (Non-GAAP) 11.7
Projected GAAP Purchases of Property, Plant and Equipment (2.2)
Projected Free Cash Flow Excluding the fairlife Contingent Consideration Payment (Non-GAAP) $ 9.5
30

-- 15 of 15 --